Skip to content
Cure Ventures
  • People
  • Companies
  • Approach
  • About
    • Overview
    • News
    • Community
    • Careers
  • Contact
Cure Ventures
  • People
  • Companies
  • Approach
  • About
    • Overview
    • News
    • Community
    • Careers
  • Contact

Latest News and Insights

Please Visit Often to Stay Current

Featured

Founder Stories

Dr. Michael Aberman’s Story Behind XenImmune

Aided by Cure Ventures’ diligent and rigorous approach to company building, we’re pioneering the platform technology of hyperacute rejection to fight cancer and I’m excited to say our lead therapy has shown proof-of-concept in in vitro and in vivo models. With the help of Cure’s seed funding and active collaboration, we continue to generate the data...
Read Post
Filter by:
  • View All
Loading...

Dr. Michael Aberman’s Story Behind XenImmune

Aided by Cure Ventures’ diligent and rigorous approach to company building, we’re pioneering the platform...
Read More
Founder Stories

Dr. Milenko Cicmil’s Story on How Tasca Came to Be

The technology behind Tasca is complex and the process of forming and growing a company...
Read More
Founder Stories

Cure Ventures Launches with the Close of Inaugural $350 Million Fund

Cure Ventures (“Cure”), a life sciences venture capital firm focusing on company formation around groundbreaking...
Read More
Cure Venture News

End of content

No more pages to load

Don't Miss a Beat

Subscribe to Our Email List

Subscribe

© 2023 Cure Ventures

  • People
  • Companies
  • Approach
  • About
  • News
  • Community
  • Careers
  • Contact
  • Privacy Policy
  • Investor Login